Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Healthspan Capital
AddedFeb 15, 2024
UpdatedJun 28, 2026
Healthspan Capital

Healthspan Capital

Operating

California-based Healthspan Capital invests in and supports longevity biotech firms.

Location
El Cerrito, CA, US
Founded
2021
Firm
Compare
Portfolio
Employees
Website

Healthspan Capital, based in El Cerrito, California, focuses on investing in longevity biotechnology companies. The firm typically participates in Seed and Series A rounds, with investment amounts ranging from several million dollars per round. Healthspan Capital is dedicated to advancing the field of biotechnology aimed at extending human healthspan and improving quality of life.

Notable portfolio companies include Deciduous Therapeutics, Repair Biotechnologies, and Reservoir Neuroscience, which have collectively raised significant funding. The firm's investment philosophy centers on supporting groundbreaking biotech innovations that target age-related diseases and enhance longevity. Healthspan Capital offers unique value-add services, leveraging deep industry expertise and strategic guidance to help portfolio companies achieve their growth objectives.

Healthspan Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments8
Current Portfolio Count7
Total Portfolio Exits0

Top Investment Stages

Seed4 (50.0%)
Series Unknown3 (37.5%)
Series A1 (12.5%)

Stage Mix

Seed 50%Series Unknown 38%Series A 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Reservoir Neuroscience logo

Reservoir Neuroscience

Repair Biotechnologies logo

Repair Biotechnologies

Deciduous Therapeutics logo

Deciduous Therapeutics

Samsara Therapeutics logo

Samsara Therapeutics

ImmuneBridge logo

ImmuneBridge

Vincere Biosciences logo

Vincere Biosciences

Immunis logo

Immunis

Healthspan Capital - Similar Investment Firms

The Longevity Fund logo

The Longevity Fund

longevity.vc

Lifespan Investments logo

Lifespan Investments

Longevitytech.fund logo

Longevitytech.fund

longevitytech.fund

Continuum Health Ventures logo

Continuum Health Ventures

continuumhealth.vc

Longevity Vision Fund logo

Longevity Vision Fund

longevity.vision

Thynk Capital logo

Thynk Capital

thynkcapital.com

Human Longevity and Performance Impact Venture Fund logo

Human Longevity and Performance Impact Venture Fund

Longevity Venture Partners logo

Longevity Venture Partners

Longitude Capital logo

Longitude Capital

Transhuman Capital logo

Transhuman Capital

Biospring Partners logo

Biospring Partners

biospring.com

Emerging Longevity Ventures logo

Emerging Longevity Ventures

LongeVC logo

LongeVC

longevc.com

PeakSpan Capital logo

PeakSpan Capital

Life Extension Ventures logo

Life Extension Ventures

lifex.vc

Healthspan Capital - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified